Biogen to Present at the Leerink Partners 6th Annual Global Healthcare Conference

CAMBRIDGE, Mass.--()--Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Leerink Partners 6th Annual Global Healthcare Conference. The webcast will be live on Wednesday, February 15, 2017 at 1:00 p.m. EST. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available following the presentation.

About Biogen
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Building on its heritage in biologics, Biogen also manufactures and commercializes high-quality biosimilars. For more information, please visit www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.

Contacts

Biogen
Karen Jewell, 781-464-2442
Investor Relations

Recent Stories

RSS feed for Biogen Inc.

Release Summary

Biogen to Present at the Leerink Partners 6th Annual Global Healthcare Conference

Biogen Inc.